Three dividend stocks that stand out as being among the most promising buys right now are Pfizer (NYSE: PFE), Suncor Energy (NYSE: SU), and Verizon Communications (NYSE: VZ). Pharmaceutical giant Pfizer is down 26% this year, performing in line with the broader markets.
GSK's specialty products like Dovato, Nucala, Trelegy Ellipta, Shingrix are driving sales, making up for the lower sales of established drugs due to generic erosion.
NEW YORK, October 05, 2022--Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities starting with sickle cell disease (SCD). The acquisition reinforces Pfizer’s commitment to SCD, building on a 30-year legacy in the rare hematology space.